We are live on
!
Find out more
DY
Dowling & Yahnke Portfolio holdings
AUM
$2.15B
Turnover
6.98%
1-Year Est. Return
10.82%
This Fund
S&P 500
This Quarter
Est. Return
+3.88%
1 Year Est. Return
-10.82%
3 Year Est. Return
+34.82%
5 Year Est. Return
+71.23%
10 Year Est. Return
–
AUM
$774M
AUM Growth
+$15.3M
(+2%)
Cap. Flow
-$9.61M
Cap. Flow
% of AUM
-1.24%
Top 10 Holdings %
Top 10 Hldgs %
26.39%
Holding
284
New
7
Increased
63
Reduced
151
Closed
12
Avg Time Held
0.9
years
Top 10 Avg Time Held
0.9
years
Top 20 Avg Time Held
0.9
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Interactive Brokers
IBKR
|
+$920K |
| 2 |
Apple
AAPL
|
+$848K |
| 3 |
Caterpillar
CAT
|
+$737K |
| 4 |
Vanguard Materials ETF
VAW
|
+$304K |
| 5 |
IBM
IBM
|
+$298K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Coca-Cola
KO
|
+$978K |
| 2 |
Reliance Steel & Aluminium
RS
|
+$643K |
| 3 |
Neurocrine Biosciences
NBIX
|
+$483K |
| 4 |
ACO
AMCOL International Corp
ACO
|
+$483K |
| 5 |
Johnson & Johnson
JNJ
|
+$450K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 20.26% |
| 2 | Healthcare | 13.17% |
| 3 | Consumer Staples | 12.92% |
| 4 | Technology | 11.77% |
| 5 | Financials | 10.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
126
Accenture
ACN
$138B
| $1.66M | 0.21% |
20,489
+1,373
| +7% | +$110K |
2013 Q2
4 quarters
|
|
127
Corning
GLW
$119B
| $1.59M | 0.2% |
72,288
-3,516
| -5% | -$74.6K |
2013 Q2
4 quarters
|
|
128
Nike
NKE
$55.2B
| $1.57M | 0.2% |
40,626
+4,476
| +12% | +$166K |
2013 Q2
4 quarters
|
|
129
Vanguard Morningstar Total Stock Market ETF
VTI
$697B
| $1.56M | 0.2% |
15,321
+7
| +0% | +$690 |
2013 Q2
4 quarters
|
|
130
PNC Financial Services
PNC
$85.7B
| $1.56M | 0.2% |
17,473
-150
| -0.9% | -$12.8K |
2013 Q2
4 quarters
|
|
131
Archer Daniels Midland
ADM
$40B
| $1.52M | 0.2% |
34,441
-1,140
| -3% | -$50.4K |
2013 Q2
4 quarters
|
|
|
132
Interactive Brokers
IBKR
$39B
| $1.52M | 0.2% |
260,800
+160,000
| +159% | +$920K |
2013 Q2
4 quarters
|
|
|
CELG
133
DELISTED
Celgene Corp
CELG
| $1.5M | 0.19% |
17,508
+1,050
| +6% | +$79.8K |
2013 Q2
4 quarters
|
|
134
iShares Russell Mid-Cap ETF
IWR
$56.6B
| $1.44M | 0.19% |
35,468
-700
| -2% | -$27.3K |
2013 Q2
4 quarters
|
|
135
iShares Russell 2000 ETF
IWM
$77.5B
| $1.4M | 0.18% |
11,787
+232
| +2% | +$26.3K |
2013 Q2
4 quarters
|
|
136
Vanguard Energy ETF
VDE
$11.2B
| $1.4M | 0.18% |
9,710
-119
| -1% | -$16.2K |
2013 Q2
4 quarters
|
|
|
YHOO
137
DELISTED
Yahoo Inc
YHOO
| $1.39M | 0.18% |
39,462
+1,640
| +4% | +$57.3K |
2013 Q2
4 quarters
|
|
138
DELISTED
Kellanova
K
| $1.38M | 0.18% |
22,301
-261
| -1% | -$16.3K |
2013 Q2
4 quarters
|
|
139
Verizon
VZ
$184B
| $1.25M | 0.16% |
25,524
-8,226
| -24% | -$399K |
2013 Q2
4 quarters
|
|
140
General Dynamics
GD
$91.2B
| $1.23M | 0.16% |
10,529
-193
| -2% | -$22K |
2013 Q2
4 quarters
|
|
141
State Street Technology Select Sector SPDR ETF
XLK
$125B
| $1.22M | 0.16% |
63,434
-116
| -0.2% | -$2.15K |
2013 Q2
4 quarters
|
|
142
Vanguard FTSE Emerging Markets ETF
VWO
$124B
| $1.21M | 0.16% |
28,053
-595
| -2% | -$25.1K |
2013 Q2
4 quarters
|
|
143
State Street Financial Select Sector SPDR ETF
XLF
$51.4B
| $1.16M | 0.15% |
58,100
-541
| -0.9% | -$10.5K |
2013 Q2
4 quarters
|
|
144
Applied Materials
AMAT
$341B
| $1.15M | 0.15% |
50,757
-2,915
| -5% | -$59.5K |
2013 Q2
4 quarters
|
|
145
Devon Energy
DVN
$54.2B
| $1.1M | 0.14% |
13,913
+25
| +0.2% | +$1.82K |
2013 Q2
4 quarters
|
|
146
Cognizant
CTSH
$29.6B
| $1.05M | 0.14% |
21,391
-885
| -4% | -$43.1K |
2013 Q2
4 quarters
|
|
|
RDS.A
147
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $1.02M | 0.13% |
13,315
-1,781
| -12% | -$130K |
2013 Q2
4 quarters
|
|
148
Vanguard Health Care ETF
VHT
$19.9B
| $977K | 0.13% |
8,752
| – | – |
2013 Q2
4 quarters
|
|
149
Saic
SAIC
$5.59B
| $951K | 0.12% |
21,534
-32
| -0.1% | -$1.26K |
2013 Q4
2 quarters
|
|
150
iShares US Basic Materials ETF
IYM
$1.36B
| $923K | 0.12% |
10,547
-2,785
| -21% | -$237K |
2013 Q2
4 quarters
|
|
Similar funds
AC
APA
IC
SCA
ACM
W
Dowling & Yahnke's Q2 2014 Portfolio in Review
As of Q2 2014, Dowling & Yahnke held 284 positions worth $774M, up 2% from $759M the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Dowling & Yahnke's Q2 2014 filing shows 7 new, 63 increased, 151 reduced and 12 closed positions. Its largest new stake was Allergan plc: 949 shares worth $212K. The largest sale was Coca-Cola, an estimated $978K.
By sector, the portfolio is most concentrated in Miscellaneous at 20% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Staples.
- Dowling & Yahnke's largest Q2 2014 buy was Allergan plc: 949 shares worth $212K.
- Dowling & Yahnke added most to Interactive Brokers in Q2 2014, an estimated $920K increase.
- Dowling & Yahnke's biggest Q2 2014 reduction was Coca-Cola, cutting an estimated $978K.
- Dowling & Yahnke fully exited AMCOL International Corp in Q2 2014, selling an estimated $483K.
- Dowling & Yahnke's ten largest holdings make up 26% of its $774M portfolio in Q2 2014.
- Dowling & Yahnke opened 7 new positions and closed 12 in Q2 2014.
- Dowling & Yahnke's portfolio value rose 2% quarter-over-quarter to $774M.
Based on Dowling & Yahnke's 13F filing for Q2 2014, filed 15 Aug 2014.